Ares Financial Consulting »

Regeneron Pharmaceuticals shares owned by Ares Financial Consulting

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Ares Financial Consulting from 13F filings

Historical chart of Ares Financial Consulting investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Ares Financial Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Ares Financial Consulting

Quarter filed Position value Share count Share price at filing
2026-03-31 $59k 76 777.54

More positions owned by Ares Financial Consulting

Vanguard Total Stock Market Etf Etf (VTI)
Wisdomtree Floating Rate Treasury Fund Etf (USFR)
Dimensional U.s. Targeted Value Etf Etf (DFAT)
Dimensional Inflation-protected Securities Etf Etf (DFIP)
Dimensional International Core Equity Market Etf Etf (DFAI)
Nvidia Corporation Stock (NVDA)
Avantis U.s. Equity Etf Etf (AVUS)
Ishares 0-5 Year Tips Bond Etf Etf (STIP)
Pimco 15 Year Us Tips Index Exchange-traded Fund Etf (LTPZ)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Saba Closed End Funds Etf Etf (CEFS)
Vanguard Total International Stock Etf Etf (VXUS)
Apple Stock (AAPL)
Dimensional International Core Equity 2 Etf Etf (DFIC)

View all positions for Ares Financial Consulting

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
State Street Corporation
Dodge & Cox
Franklin Resources
Geode Capital Management
FMR
Nuveen
Loomis, Sayles and
Invesco
Capital World Investors
Susquehanna International
Goldman Sachs Group
Norges Bank Investment Management
AQR Capital Management

View all funds holding Regeneron Pharmaceuticals